Section Arrow
PEN.NYSE
- Penumbra
Quotes are at least 15-min delayed:2026/03/12 02:21 EDT
Regular Hours
Last
 336.11
-0.63 (-0.19%)
Day High 
337.92 
Prev. Close
336.74 
1-M High
344.53 
Volume 
692.41K 
Bid
325.39
Ask
355
Day Low
334.83 
Open
337.07 
1-M Low
336.64 
Market Cap 
13.21B 
Currency 美元 
P/E 74.5 
%Yield -- 
10-SMA 340.27 
20-SMA 339.96 
50-SMA 337.71 
52-W High 362.41 
52-W Low 221.26 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.52/6.14
Enterprise Value
13.41B
Balance Sheet
Book Value Per Share
36.38
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.40B
Operating Revenue Per Share
25.36
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.